Fidelity Advisor Biotechnology Fund Current Assets

Fidelity Advisor Biotechnology Fund's current assets stands at $130M as of February 2024. That compares with $150M in the prior-year period — down 13.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Fidelity Advisor Biotechnology Fund reported $130M in current assets versus $150M a year earlier — a 13.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $150M in the prior-year period — down 13.3% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Fidelity Advisor Biotechnology Fund's current assets evolved across reporting periods, while the comparison chart places FBTIX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.